Clinical Trial Update: Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluates the efficacy of vardenafil in symptomatic benign prostatic hyperplasia. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Vardenafil (vardenafil)

Snippet

Sponsor: Bayer | Conditions: Benign Prostatic Hyperplasia | Phase 2 | Status: COMPLETED